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Abstract 
Introduction and background:  
In recent decades diabetes mellitus has become a considerable health problem in 
countries like Sri Lanka and results in an increasing economic burden hampering the 
social and economic development of these countries. About 60 to 70 % of the rural 
population in Sri Lanka rely on indigenous medicinal systems as their main source 
for primary health care. Siddha (Tamil) Medicine is one of the four Sri Lankan 
traditional medicinal systems and it is practised mostly in the eastern and northern 
provinces of Sri Lanka where the majority of Tamils reside.  
Aim:  
The foundation of this study is a documentation of plant species recorded in 
historical and modern Sri Lankan Siddha Medical documents used to treat diabetes. 
Based on the systematic documentation and analysis of Siddha concepts about 
diabetes and its signs and preparations used to treat diabetes in Sri Lankan Siddha 
Medicine, the plant species included in these preparations (excluding globally or very 
widely used, very well studied species) were evaluated in terms of the current state-
of-the-art about these species’ pharmacology and effectiveness in order to lay a 
foundation for their further development.  
Method:  
Historic and modern Sri Lankan university texts books in Tamil were used as sources 
for information on diabetes Siddha concepts and antidiabetic Sri Lankan Siddha 
Medicine preparations. Information on the known antidiabetic effects of extracts and 
compounds obtained from these species were used in order to assess the current 
state of the art of these species.  
Results and discussion:  
Information of ingredients, preparation methods, amount of ingredients used, and 
dosages of 60 antidiabetic Sri Lankan Siddha Medicine preparations were obtained. 
Animal parts including marine organisms, inorganic substances, and plants are the 
three types of ingredients used. Overall 171 plant species in 73 families were 
documented. Senna auriculata (L.) Roxb. (Fabaceae) was identified as the most 
frequently cited species. Globally distributed and very well studied plants were 
excluded in the pharmacological and clinical literature review which includes 123 
plant species. The majority (48 %) of the plant species reviewed were studied up to in 
vivo level as the current maximum level of scientific evidence available. Followed by 
41 % of species have not been studied for antidiabetic activities or did not show 
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antidiabetic activity. Moreover, 6 % and 5 % were studied up to in vitro and in clinical 
levels, respectively.  The majority of the species were studied only in the models that 
represent type 1 diabetes.  
Conclusion:  
This is the first study systematically assessing the importance of preparations and 
plants used in antidiabetic Sri Lankan Siddha Medicine preparations. Antidiabetic 
plants are a crucial health care resource in Sri Lankan Siddha Medicine. This study 
also identified a wide range of methodological problems in the studies conducted so 
far. More and better type 2 diabetes models should be employed in future studies. 
This comprehensive review creates the basis for a more systematic study of these 
local resources. 
 
List of abbreviations 
DM, diabetes mellitus; SM, Siddha Medicine; SL, Sri Lanka; T1DM, type 1 diabetes 
mellitus; T2DM, type 2 diabetes mellitus 
 
Keywords: Alpha glucosidase inhibition assay, alpha amylase inhibition assay, 
Diabetes Mellitus, Fabaceae, Senna auriculata, Siddha Medicine, Sri Lanka, 
Streptozotocin, Tamil Medicine 
 
1. Introduction  
Diabetes mellitus (DM) has become an enormous and fast developing health 
problem and is an increasing economic burden hampering the social and economic 
development of many countries. Undiagnosed cases cause greater risk of elevating 
cost and dangerous complications (IDF, 2014). In 2015, globally 415 million (215.2 
million men and 199.5 million women) people had DM with a prevalence of 8.8 %. In 
other words, one in eleven people have DM (IDF, 2015). Nearly 90 % of people with 
DM around the world have type 2 DM (T2DM) (WHO, 1999) and in every country the 
number of people with T2DM has been increasing mostly dramatically (IDF, 2014). 
The majority of people with DM live in urban areas (269.7 million; with 145.1 million 
in rural areas). In China alone there are 109.6 million cases (IDF, 2015). Moreover, the 
majority (320.5 million) of people with DM are in the 20 – 64 age range. In 2015, 5 
million DM related deaths were reported and there were an estimated 192.8 million 
undiagnosed cases (46.5 %). The highest proportion of undiagnosed cases are found 
in Africa (66.7 %) (IDF, 2015). Every six seconds one person dies from DM. 
Importantly, 77 % of the diabetics live in low and middle income countries, and thus 
have a much more limited access to biomedical health care (IDF, 2014). 
In 2015, globally US$ 673 billion (12 % of health expenditure) was spent on treating 
DM whereas the USA is the country with the highest costs (US$ 320 billion) (IDF, 
2015). Europe has the highest prevalence of children with T1DM. For 2040, it is 
estimated that 642 million people will have DM representing a global DM prevalence 
of 10.4 %.  
In South Asia (Bangladesh, Bhutan, India, Maldives, Nepal, and Sri Lanka (SL)) and 
Mauritius, in 2015 there were 78 million diabetics and by 2040 this will increase to 
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140 million (IDF, 2015). One in twelve people in this region has DM (IDF, 2014). 
Again, in 2015 there were 40.8 million undiagnosed cases and DM caused 1.2 million 
deaths in South Asia and Mauritius area. Some 53 % of those deaths were in people 
under 60 years old. More women (664,071) died than men (524,394) with DM, 
whereas majority of people with DM died in India in this region. The largest number 
of diabetics (20 to 79 years) in South Asia and Mauritius area lives in India (69 
million).  
In SL, in 2015 there were 1.2 million diabetics including 625,000 undiagnosed cases 
(20 to 79 years) (IDF, 2015). One in twelve people had DM (IDF, 2014). In 2015, 16,318 
deaths (20 to 79 years) were caused by DM. The cost per diabetic is US$ 429.2 (IDF, 
2015). Overall, there is a need to develop national and regional strategies to prevent 
the development of DM and to mitigate its effects (Home et al., 2013).  
 
1.1. Plants, traditional medicines, and diabetes - globally 
Plants have been used in traditional medicines to treat vast number of disorders 
including DM for centuries and these are easily available and affordable (Nearing, 
1985). Traditional Medicine preparations could be a potential source of novel 
antidiabetic compounds (Marles and Farnsworth, 1995) or phytomedicines / 
supplements. Metformin (a biguanide) is a primary line drug currently used to 
control DM in Biomedicine which was developed from galegine (a guanidine) 
isolated from Galega officinalis L. (Fabaceae) (Witters, 2001).  
In recent years systematic studies and comparative reviews have been published 
highlighting the importance of antidiabetic plants in countries, like India (Grover and 
Yadav, 2002), Nigeria (Ezuruike and Prieto, 2014), and Mexico (Andrade-Cetto and 
Heinrich, 2005). In the USA 22 % of people with DM use herbal therapy and 31 % use 
dietary supplements (Shane-McWhorter, 2009).  
 
1.2. Plants, traditional medicines, and diabetes - in Sri Lanka 
About 60 to 70 % of the rural population in SL use indigenous medicinal systems as 
their main source for primary health care (Perera P.K., 2012). Siddha (Tamil) Medicine 
(SM) is one of the four traditional medicinal systems currently practised in SL 
(Weragoda, 1980) and it is practised mostly in the east and north provinces of SL 
where the majority of Tamils reside (Sivashanmugarajah, 2000). People with DM very 
commonly use herbal supplements in SL (Medagama et al., 2014). A review of plants 
used to treat DM in SL by Ediriweera and Ratnasooriya (2009) only includes 
information collected from Ayurvedic and traditional physicians in south, west, and 
Sabaragamuva provinces of SL, where SM is not practised. Only a few ethnobotanical 
surveys and clinical studies of SM preparations have been carried out in SL. Recent 
ethnobotany surveys in Sillalai, Jaffna (Rajamanoharan, 2013) and Asikulam, Vavuniya 
(Rajamanoharan, 2014) revealed that medicinal plants are mostly used to treat  
disorders including DM. Arugankattai (அககைட) (Gly-Cyn-Neu), literally 
Glycyrrhiza glabra L. and Cynodon dactylon (L.) Pers. for neuropathy,  is a topical, two 
component Siddha preparation used to treat neuropathy.  Recent clinical studies of 
topically administering Arungankattai to people with DM for 4 weeks showed 
effective improvements in in diabetic complications without any side effects 
(Rajamanoharan and Sewwandi, 2013).  However, no detailed review of plants used 
in Sri Lankan SM is available. Recently a book written in Tamil, “A handbook of herbs 
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for healthy life” (	லிைகக ஆேராகிய வா பறிய ைக - 
Moolihaihalum Aarokkiya Vaalvum Patiya Kainool) (Rajamanoharan and Sivathas, 
2014) provides a description of herbs and practical advice to prevent and treat 
several simple disorders at home focusing on the needs of rural Tamil populations 
around the world. The search for novel AD medications from Indian Traditional 
Medicine (Marles and Farnsworth, 1995) continues and since SM has not been 
studied in any great detail, it offers unique opportunities.  
 
2. Aim 
With a lack of critical appraisal of medicinal plans used in SM in the treatment and 
management of DM, this review aims at: 
 Presenting a comprehensive review of DM in SM including the indigenous 
concepts about its symptoms.  
 Reviewing information on local and traditional uses of antidiabetic SL SM 
preparations as they are recorded in historical and modern documents.  
 Assessing the reported scientific evidence for the effectiveness of the plants 
used in those preparations.  
3. Background and methods 
3.1. Diabetes mellitus  
DM's symptoms are well known including hyperglycemia with a wide range of 
complications (Singh et al., 2014) including damage to the nervous system, blood 
vessels, eyes, gums and teeth, heart, kidneys, or feet and skin (Zaccardi et al., 2015). 
Three groups are distinguished: (1) Autoimmune T1DM or insulin dependent DM or 
juvenile DM (2) T2DM or noninsulin dependent DM or Maturity Onset DM and (3) 
Gestational DM. All forms of DM are treated by dietary control. However, T1DM 
requires insulin replacement via injection of hormone or Islet transplantation. Novel 
delivery via oral, inhaled and sublingual routes are the topic of intense current 
investigation (Shahani and Shahani, 2015). T2DM is considerably more amenable to 
therapeutic drug intervention and is treated with insulin secretagogues e.g. 
sulphonylureas, megltinides, incretins; insulin sensitisers e.g. thiazelidendiones, 
metformin; direct reduction of plasma glucose e.g. SGLT2 inhibitors, metformin 
(Bailey et al., 2016) and there are a wide range of preventive interventions under 
development (Breeze et al., 2015). Natural products and herbal medicines that have 
claimed to be effective in the treatment of DM are thus most effective in the 
treatment of T2DM (Kouzi et al., 2016). As discussed earlier this is fortunate as T2DM 
is the form of DM that makes up the major part of the global epidemic. 
 
3.2. Bioassays and in vivo models used for studying andtiiabetic activity  
Diverse models have been employed to investigate antidiabetic effects of Siddha 
medicinal plants. Pharmacodynamic models include in vitro bioassays, in vivo and 
clinical models and their relevance with regards to assessing the antidiabetic effects 
of SM vary. There are a large number of targets and bioassays used for T2DM. In 
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ethnopharmacology studies the following bioassays and in vivo models are 
particularly widely used.  
 
3.2.1. In vitro bioassays  
α-glucosidase and α-amylase inhibition assays are commonly employed to 
investigate anti-diabetic activity in in vitro studies. Bioassays such as Acetyl CoA 
carboxylase 1 enzyme bioassay and Acetyl CoA carboxylase 2 enzyme bioassay which 
are closely related in developing T2DM (Munday, 2002). Currently α-glucosidase 
inhibitors such as acarbose and miglitol are prescribed in Biomedicine. However, 
they cause unwanted adverse side effects such as abdominal pain, diarrhoea, 
bloating, and passing of gas (TASHSP, 2016a; 2016b).  
The advantages of in vitro bioassays are economic, less time consuming, and more 
samples can be screened. However, a major disadvantage is that anti-diabetic activity 
against a single target can only be tested in each bioassay rather than general anti-
diabetic activity against the pathological phenotype.  
 
3.2.2. In vivo models 
In vivo anti-diabetic activity is studied in T1DM and type T2DM animal models 
typically rat and mouse. The advantage of these studies is that one can observe 
therapeutic effects on physiology, although one might not know the true drug target 
that achieves that effect.  
 
3.2.3. Type 1 diabetes animal models  
In T1DM, β cells in pancreas are destroyed and do not secrete adequate insulin. 
Streptozotocin and Alloxan induced diabetic animal models are commonly used to 
investigate T1DM (King and Bowe, 2016; King, 2012). Streptozotocin [2-deoxy-2-(3-
(methyl-3-nitrosoureido)–D-glucopyranose] and Alloxan (2,4,5,6-tetraoxypyrimidine; 
5,6-dioxyuracil) both are toxic to β cells in pancreas and destroy them (Szkudelski, 
2001). However, constant and everlasting DM conditions can be obtained in 
streptozotocin induced diabetic models. On the other hand, both Alloxan and 
Streptozotocin induced diabetic in vivo models are not identical to human diabetic 
conditions (Islas-Andrade et al., 2000). The advantages of chemically induced DM 
animal models are that they are relatively simple and cheap (Dufrane et al., 2006) 
and the disadvantage is Streptozotocin and Alloxan can be toxic to other body 
organs (Lee et al., 2010). Another advantage is that both do mimic the pathological 
consequences of DM i.e. hyperglycaemia, glycosuria, ketoacidosis etc. Both can 
rapidly produce the symptoms of insulin deficiency. However, apart from toxicity a 
disadvantage is that they are T1DM models and this is not really a druggable 
condition and hence not ideal for investigating natural products that would treat 
T2DM. 
 
3.2.4. Type 2 diabetes animal models  
T2DM is characterised by insulin resistance and a diminished capacity for insulin 
secretion by β cells. Thus insulin resistance animal models are employed to 
investigate T2DM. Obesity is closely associated with T2DM progression linked 
through the fatty acid induced insulin resistance discussed above. Therefore obese 
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animal models are used in the investigations because they replicate human 
conditions. For example, obesity induced hyperglycemia models such as db/db 
mouse, KKAy mouse, and high fat fed animal models are employed to investigate 
T2DM. There are genetic models of obesity and T2DM e.g. ob/ob and db/db mice, 
fa/fa and OLETF rats. There are also non-obese genetic T2DM models e.g. Goto-
Kakizaki (GK) rat. All require a mention and perhaps even an explanation e.g. role of 
hyperphagia and obesity. Then there are the obesity-induced models. There are 
many of these and most involve increased calorie intake through increased fat 
feeding or fructose feeding (the latter is very popular because it mimics human 
consumption of fizzy drinks) (King and Bowe, 2016; King, 2012).  
 
3.3. Siddha / Tamil Medicine (சித / தமி ைவதிய – Siththa / Thamil 
Vaiththiyam) 
SM is based on Saiva philosophy (ைசவ சிதாத - Saiva Siththantham). Saivism 
or Saivam (ைசவ - Saivam) is one of the six branches of Hinduism religion (இ! 
சமய – Inthu samayam) which reveres Sivaperuman (சிவெப$மா%) as the 
principle God. SM is believed to have originated in ancient Tamil regions in southern 
India in the era of BCE 10 000 to BCE 4 000 (NIS, 2015). It is currently practised 
mostly in Tamil speaking regions in India, SL, and around the world (AYUSH, 2010).  
Siththa (சித) means “heavenly bliss” or “achieving perfection” or “established 
truth”. A person who achieved this status and can relieve human suffering is called 
Siththar (சித&). They are considered to be super humans with great intelligence, 
culture, and powers and spiritual scientists discovered and explained the association 
between human and nature by supernatural powers and experimental discoveries. 
There are 18 Siththars who have contributed to SM (NIS, 2015; ISM, 2011; 
Uthamaroyan, 1992; Piet, 1952): Agathiyar (அகதிய&), Thirumoolar (தி$	ல&), 
Bogar (ேபாக&), Konganar (ெகாகண&), Therayar (ேதைரய&)¸ Korakkar 
(ேகாரக&), Karuvooraar (க$(ரா&)  , Idaikkaadar (இைடகாட&), Sattamuni 
(சைட)ன+), Suntharaananthar (,தரானத&), Iraamathevar (இராமேதவ&), 
Paampaatti (பாபா-), Machchamuni (ம.ச)ன+), Kuthampai (/தைப), 
Aluhannar (அ0க1ண&) , Ahappe (அக2ேப), Nanthithevar (நதிேதவ&), and 
Kahapusundar (காக4,த&). There are some general philosophical concepts of 
Siththars which include “food is medicine, medicine is food” (உணேவ ம$!, 
ம$ேத உண - unave marunthu, marunthe unavu) and “sound mind makes a 
sound body” (மனம! ெசைமயானா மதிர ெசப6க ேவ1டா - 
manamathu semmaiyaanaal manthiram sebikka vendaa) (NHPI, 2015). There are a 
few notable Sri Lankan Siddhars lived in north and east SL. Especially Yogarswami 
(ேயாக&,வாமி) who lived half a century ago and his guru Sellappa Swami 
(ெசல2பா ,வாமி) are very well known around the world.  
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SM is less known to the western world because most of the Siddha literature are still 
in Tamil and have not been translated (Thas, 2008). However, it was recognised by 
Biomedicine as an alternative East Indian medicinal system predominant within Tamil 
communities (Stephen E.S., 2005). The aims of SM are to make the body perfect, 
imperishable, and promote longevity and it is the first medicinal system to emphasis 
health as the perfect state of mental, physical, moral, social, and spiritual element of 
humans (ISM, 2011). 
As SM philosophy is developed in the medicinal, spiritual, and intellectual aspects, it 
provides equal importance to internal soul and external body, diagnosing methods 
especially urine investigation (ந7&/றி - neerkkuri), alchemy (converting base 
metals into gold) and materia medica (using enormous range of ingredients) are the 
uniqueness of SM over the other Traditional Medicines including Ayurveda (AYUSH, 
2010; Narayansami, 1975). Currently SM is accepted as being suitable to treat all 
disorders expect emergency cases (AYUSH, 2010). Also herbomineral or herbometal 
preparations which contain nanoparticles are more effective in life threatening and 
chronic disorders (ISM, 2011). 
The principle of SM is the ‘universe-body’ principle (அ1டப61ட த!வ – 
andapinda thaththuvam) or the association between the universe and human body. 
The physical structure of the human body (உட தா!க8 – udal thaathukkal) is 
composed of five elements (ப9ச:தக8 – panjapoothangal) which are earth 
(நில – nilam), water (ந7& – neer), fire (ெந$24 – neruppu), wind (வள+ – vali), 
and sky (ஆகாய – aahaayam). Human body functions are retained by the 
physiological units (உய6& தா!க8 – uyir thaathukkal) also called three forces or 
faults, which are wind (வாத – vaatham), bile (ப6த – piththam), and phlegm 
(சிேலபன – siletpanam). Imbalance of these three forces causes illnesses 
(Narayansami 1975). Every living body is sustained by seven fundamental tissues 
(ஏ0 தா!க8 – elu thathukkal) which are, lymph (சர – saram), blood (/$தி 
– kuruthi), flesh (ஊ% – oon), fat (ெகா024 – koluppu), bone (எ?4 – elumbu), 
marrow (	ைள – moolai), and semen (ெவந7& – veneer) (Shanmuka Velu, 1987).  
There are eight Siddha diagnostic methods: pulse examination (நா- – naadi), touch 
(ப@ச – parisam), tongue examination (நா – naa), body colour (நிற – niram), 
speech (ெமாழி – moli), eye (வ6ழி – vili), stool (மல – malam), and urine 
(	திர – mooththiram). Another diagnotic method called urine investigation 
(ந7&/றி – neerkkuri) is a unique to SM. A sesame oil drop placed over urine and its 
shape and spreading patterns are observed. The fundamental principle of this 
diagnosis is linked to the surface tension of urine (Narayansami, 1975). 
Sidhar Yugimuni (சித& Bகி)ன+ – Siththar Yuhimuni) identified 4448 disorders 
(ISM, 2011) and there are three types of treatments: divine (ேதவ ம$!வ – 
theva maruththuvam), rational (மான+ட ம$!வ – maanida maruththuvam), 
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and surgical treatment (அ,ர ம$!வ – asura maruththuvam). Also there are 
three types of medications which are, miracle, sophisticated, and common 
medications. Drug ingrdeients are classified into three and they are herbal (தாவர 
வ&க – thaavaram varkkam), inorganic (தா! வ&க – thaathu varkkam), 
such as metals and minerals, and animal products (ஜ7வ வ&க – jeeva varkkam) 
(NIS, 2015). More than 80 % are herbal products (ISM, 2011). Treatments are 
individual as they are provided considering environment, patient, age, sex, lifestyles, 
habitat, mental state, meteorological condition, appetite, physiological structure, and 
physical state which reduces diagnosis and treatment faults (AYUSH, 2010).  
 
3.4. Antidiabetic Sri Lankan Siddha preparations sources 
The documents used to obtain information on antidiabetic SL SM preparations are 
current university text books which were originally from SL and written in Tamil. They 
are used as teaching material in Bachelor of Siddha Medicine and Surgery (BSMS) 
degree in the universities in SL and thus form the basis for Siddha practice:   
1. Pararasaseharam (Fifth Part) (பரராசேசகர (ஐதா பாக) - 
Pararaasaseharam (Ainthaam Paaham)): This book was compiled under King 
Pararaasaseharan (பரராசேசகர%) between 1478 and 1519. It was initially printed 
as a book in 1935 by Ponniapillai, I. in Mallaaham and reprinted in 2003 by Sripathy 
Sarma, P. and published by Niyanthree Publication in Nallur, Jaffna, SL. (Anonymous, 
2003).  
2. Seharaasasehara Treatment (ெசகராசேசகர ைவதிய - Seharaasasehara 
Vaiththiyam): Contents of this book were compiled under King Seharaasaseharan 
(ெசகராசேசகர%) between 1380 and 1414. It was first printed in 1927 by 
Ponniapillai, I. and reprinted in 2000 by the Provincial Department of Indigenous 
Medicine, Ministry of Health north and east Provinces. (Anonymous, 2000). 
3. Siddha Medicinal Procedure (சித ஔடத ெசF)ைற - Siththa Audatha 
Seimurai): This book was compiled by S.M. Ponniah and I. Sabapathipillaiin 1980 and 
published by Department of Ayurveda, Ministry of Health & Indigenous Medicine. 
(Ponniah and Sabapathipillai, 1980).  
Only Anonymous (2003) and Anonymous (2000) contain the information about the 
symptoms and causes of DM as well as information of preparations, however source 
three (Ponniah and Sabapathipillai (1980)) only contains information on 
preparations. SL origin preparations are only considered in this study and few 
preparations mentioned on source three were excluded as they were stated as Indian 
origin.  
 
3.5. Characteristics of diabetes in Siddha Medicine  
In the following causes and signs which are seen to the Siddha correspondence of 
DM are described. The description is based on Siddha texts and as such follows the 
principles of Siddha medical theory. Generic term Diabetes Mellitus (DM) is used, 
since a distinction of T1DM or T2DM is not meaningful in this context. In 
Pararaasaseharam (Fifth Part) (Anonymous 2003) DM is called as losing water 
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(ந7@ழி – neerilivu; சலகழி.ச – salakkalichchal), water related disease 
(சலேராக – salaroham), and sweet urine (ம!ேமக – mathumeham) in SM 
and it is characterised by frequently passing hot urine, passing foamy urine like a 
pearl (drop) of fresh honey in the water, and this is an incurable disease (Anonymous, 
2003). It is grouped within the polyuria related conditions (ேமகேநாF – mehanoi) 
of which there are 20 types. These are categorized into three groups: fire 
(ப6தேமக – piththameham) (6 types), wind (வாதேமக – vaathameham) (4 
types), and water related polyuria conditions (சிேலபனேமக – 
siletpanameham) (10 types).  Moreover, DM is considered as one of the wind related 
polyuria related condition.  
 
3.5.1. Causes of diabetes 
Consumption of ghee (semifluid butter), curd, and milk (which increase the coolness 
of the body), consumption of meat, not applying oil on the body, excessively walking 
in the sun, and excessive sexual intercourse with woman are considered to be causes 
of DM (ந7@ழி – neerilivu) (Anonymous, 2000).  
Consuming excess or dearth food (eating disorder), having meals at irregular times 
(irregular eating), excess consumption of ghee and milk, excessive consumption of 
sour foods and Irasam (இரச). Irasam is a decoction (common dish) which is 
served with meals especially lunch and it is prepared using  Cuminum cyminum L. 
dried fruit (Apiaceae), Coriandrum sativum L. dried fruit, Allium cepa L. 
(Amaryllidaceae) fresh bulb, A. sativum L. dried bulb, Tamarindus indica L. (Fabaceae) 
dried fruit juice, Piper nigrum L. (Piperaceae) dried fruit, Murraya koenigii (L.) Spreng. 
(Rutaceae) fresh leaf, Capsicum annuum L. (Solanaceae) dried fruit, and Curcuma 
longa L. (Zingiberaceae) dried rhizome powder. Also having excessive sexual 
intercourse with a woman and excessively walking in the sun during summer may 
cause DM (Anonymous, 2000).  
 
3.5.2. Signs of diabetes 
The signs of DM (ந7@ழி – neerilivu) include feeling laziness, excessive sweating, 
body odour, always wanting to sleep, dry tongue, grease formation on tongue, sweet 
taste in mouth, desiring to consume cold drinks and foods, dry chest and throat, 
rapid growth of hair and nail, and ants and flies gather around the urine 
(Anonymous, 2003). 
The signs in Anonymous (2000) are somewhat different and include burning 
sensation in the stomach, paleness of body skin, weight loss, consciousness loss, dry 
tongue, feeling thirsty, excessive urination during the night (nocturia), difficulty in 
walking, blurred vision on humid, foggy, and rainy days, excessive urination, and 
feeling depressed.  
Another set of signs is described including burning sensation in the stomach, 
sweating, difficulty in walking, blurred vision, wanting to quench thirst by drinking 
buttermilk (whey) and coconut water, loss of appetite, dry tongue, body ache, 
passing clear and foamless urine during day and night, extreme pain, ear congestion, 
and unable to fall asleep (insomnia) (Anonymous, 2000).  
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Additionally, sweet taste of urine, gathering of ants and flies on urine, passing urine 
with properties of coconut water during the night, dry tongue, feeling thirsty, body 
weakness, laziness are seen as signs and may cause death (Anonymous, 2000). 
 
3.5.3. Types of diabetes  
In SM 24 types of neerilivu (what according to the textbook is considered to be DM) 
are distinguished and further divided into seven categories. These categories are 
based on the impact the basic elements have on the human body and the types are 
identified based on the taste and odour of the urine. The seven categories are: 
1. Wind associated DM (வாத ந7@ழி – Vaatha neerilivu) including three types. The 
urine can be characterised by: 
 An odour of Mangifera indica L. (Anacardiaceae) flower and sour taste, or  
 An odour of Crocus sativus L. (Iridaceae) flower and sour-bitter taste. 
2. Wind-fire associated DM (வாதப6த ந7@ழி – Vaathapiththa neerilivu) 
including four types. The urine can be characterised by: 
 An odour of Curcuma longa L. rhizome (Zingiberaceae) and sour-bitter taste, 
 An odour of Nerium oleander L. (Apocynaceae) flower and sweet-pungent-
bitter-sour-astringent taste,  
 An odour of milk and buttery taste, and  
 An odour of brain odour and bitter taste. 
3. Fire associated DM (ப6த ந7@ழி – Piththa neerilivu) including three types. The 
urine can be characterised by: 
 An odour of fruit juice and bitter taste,  
 A salty odour and taste, and  
 An odour of Jasminum sambac (L.) Aiton (Oleaceae) flower and producing a 
burning sensation when urinating 
 
4. Fire-wind associated DM (ப6தவாத ந7@ழி – piththavaatha neerilivu) 
including two types. The urine can be characterised by: 
 An odour of cow urine and astringent taste and  
 An odour of Santalum album L. (Santalaceae) wood and peppery taste. 
 
5. Water associated DM (சிேலபன ந7@ழி – Siletpana neerilivu) including four 
types. The urine can be characterised by: 
 An odour of Pandanus odorifer (Forssk.) Kuntze (Pandanaceae) flower- cow 
manure-lemon-blood and sweet taste. 
6. Water-fire associated DM (சிேலபனப6த ந7@ழி – Siletpanapiththa 
neerilivu) including four types. The urine can be characterised by:  
 An odour of Magnolia champaca (L.) Baill. ex Pierre (Magnoliaceae) flower, 
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 A taste like Syzygium cumini (L.) Skeels (Myrtaceae) fruit,  
 A bad odour and a bitter-sour taste as well as ants gathering around the 
urine, and  
 An odour of slaked lime (calcium hydroxide) and producing a burning 
sensation (similar to the one caused by lime (calcium oxide) when urinating.    
7. Water-wind associated DM (சிேலபனவாத ந7@ழி – Siletpanavaatha 
neerilivu) including four types. The urine can be characterised by:  
 A strong odour and sour taste. (Sithamparthanuppillai, 1982).   
 
3.5.4. Diabetes complications 
Like in Biomedicine DM complications have been reported in SM. Some of the 
complications include lower abdominal pain, tiredness after urinating, flatulence , 
increased deficiency in sperm secretion, sperm in urine, general body weakness, loss 
of appetite, abscess formation, diarrhoea, unconsciousness, and death 
(Sithamparthanuppillai, 1982).   
 
3.6. Methods 
Information of the antidiabetic SL SM preparations were obtained from the text 
books which were written / complied and currently used in the universities in SL (see 
section 3.4. Antidiabetic Sri Lankan Siddha preparations sources). Scientific names of 
the plants used in the preparations are based on Sugathadasa et al. (2008) and 
validated on http://www.theplantlist.org. Since historical documents are used as a 
source in this work, there might be some discrepancies of the plant species 
mentioned in the original sources and botanically identified. Therefore all plant 
species names are validated taxonomically but the exact botanical identification is 
based on the information available in the historical and other archival documents 
only and based on the accepted names in these written sources. Both, accepted and 
synonym (in brackets), names are stated for those found on Checklist of Medicinal 
Plants of SL as synonym. The family names of the plant species were validated using 
APG III (2009).  
In order to assess what is known in bioscientific and biomedical terms about these 
species, relevant literature was identified through Web of Science electronic 
database searches until January 2016. Antidiabetic pharmacology studies only 
associated with activities of reducing blood glucose levels and inhibition activity of 
enzymes such as α-amylase and α-glucosidase were considered and studies of DM 
complications were excluded. Also species stated in AHP (2011), Brendler et al. 
(2010), EMA (2009), Upton et al. (2011), WHOMSM1 (1999), WHOMSM2 (2004), 
WHOMSM3 (2007), and WHOMSM4 (2009) were excluded from further analysis and 
thus from the search.  Both genus and species names together in double quotation 
marks (" ") was used as a primary search and the results were refined by using 
diabet* as a secondary search term. 
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4. Results and discussion  
4.1. Siddha treatments for diabetes  
DM is diagnosed by local Siddha healers and academic Siddha medical doctors by 
pulse reading and odour and taste of the urine and is not based on a biomedical 
diagnosis. Oral preparations such as pills, powders, decoctions, diets, oils as well as 
topical creams are used as preparations with pills are the most common formulation 
used. Preparations are provided at state Siddha hospitals which are manufactured in 
large scale by SL Ayurveda Drugs Corporation in SL and are also imported from India 
(MIM, 2013).  
Preparations provided by local Siddha healers are prepared by themselves at their 
homes. Consequently, there is some variability in their composition if an ingredient is 
unavailable then it is simply left out. However, the absent ingredient(s) might be the 
principle component with more effect in that particular preparation. According to 
Siddha concepts, if such an ‘incomplete’ preparation is taken by the patients, the full 
recovery or effectiveness is not achieved affecting the reliability of Traditional 
Medicine treatments. On the other hand, preparations provided at state Siddha 
hospitals contain all the ingredients and as such seem to be more consistent in their 
composition.  
Adjuvants like honey, decoctions or buttermilk are usually taken with these SM 
preparations, whereas, in Biomedicine no such adjuvants are used. Adjuvants are 
recommended; however, they are not supplied by either state Siddha hospitals or 
local Siddha healers. Therefore adjuvants have to be prepared by the patients. Diet 
management is currently recommended by Biomedicine and this is also 
recommended in SM. Dietary items are consumed together with the specific 
antidiabetic preparations. Again diets are not compulsory but are recommended for 
achieving better treatment outcomes. When consuming some preparations certain 
foods should be avoided. For  example, fish, bitter and sour foods should be avoided 
while taking preparation 14 (Suravappidippaanundai - ,வற2ப6-2பாG1ைட 
) (see Appendix B).  
 
4.2. Comparison of diabetes concepts in Biomedicine and Siddha Medicine  
Since Banting and Best’s discovery in 1921 (Nobel Media AB, 2014) that an extract 
from cattle foetal pancreas lowers blood sugar levels of depancreatised dogs, DM 
has become a more and more prominent part of the biomedical research and 
practice. The typical biomedically recognised symptoms of DM are well known as is 
the treatment with associated changes in a patient’s lifestyle (ADS, 2015). 
There are some similarities and differences between Biomedicine and SM in 
definition, causes, types, diagnosis, treatment, and complications of DM. In SM 
(especially in the earlier textbooks) the causes of DM are linked to the consumption 
of unsuitable diets rich in animal fat and social behaviour (see section 3.5.1. Causes 
of diabetes) and not to biomedical changes in the human body. In both Biomedicine 
and SM DM is considered as a polyuria associated condition. Biomedicine defines DM 
as “excessive secretion of sweet urine” while SM defines as “passing foamy urine like 
a pearl of fresh honey in the water”. Furthermore, both medicinal systems consider it 
as  an incurable disorder and the symptoms such as frequent urination, excessive 
thirst, blurred vision and weight loss are also mentioned in both systems. In 
Biomedicine DM is classified into three types whereas in SM 24 types in seven 
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categories are distinguished. It is diagnosed by various blood tests in Biomedicine 
whereas SM uses a diagnosis based on the odour and taste of the urine. Biomedicine 
states that one the reasons for body odour or insomnia is DM, which are indicated as 
symptoms in SM. In Biomedicine Fuchs' dystrophy (build-up of fluids in cornea 
tissues in eyes) symptoms have been found to be more severe on a humid or rainy 
day and one of the diabetic ketoacidosis (a diabetic complication) symptoms, sweet 
taste in mouth, were mentioned as symptoms of DM in addition in SM (Anonymous, 
2000). Moreover, in both systems, oral administration of medications is employed. In 
SM decoctions and powders may be used In SM uses topical preparations (e.g. oils 
and creams) may also be used while injections are used in Biomedicine.   
Biomedicine remedies are known to cause several unwanted adverse side effects 
while these are not mentioned in SM. Furthermore, as SM treatments are individual, it 
is assumed that they cause less or no side effects. However, there is no scientific 
evidence base for the latter.  
 
4.4. Antidiabetic Sri Lankan Siddha preparations – an overview   
 
4.4.1. Ethnobotanical analysis and types of plants used in the antidiabetic Sri 
Lankan Siddha preparations  
Family and scientific name, Tamil name, part used, preparation, and source of 171 
plants in 73 families which are recorded in the SL SM preparations used to treat DM 
are presented in Appendix A. The most frequently used species is Senna auriculata 
and the largest number of taxa is from the Fabaceae.  
Detailed information of ingredient (scientific or English name), family (where 
applicable), amount used (converted to metric units from Tamil units where 
applicable), preparation procedure, and dosage of 60 antidiabetic SL SM 
preparations obtained from the sources earlier mentioned in the background and 
methods (see section 3.4. Antidiabetic Sri Lankan Siddha preparations sources) are 
not solely used to treat DM and they are also used to treat several other disorders 
which are not related to DM. There are several other common preparations also 
available to treat all 20 types of polyuria associated conditions. Preparations 
particularly mentioned to treat DM are only presented in this Appendix B.  
Anonymous (2003) contains the largest number of antidiabetic SL SM preparations 
followed by Anonymous (2000), and Ponniah and Sabapathipillai (1980). Oral and 
topical preparations are used to treat DM. Pills, powders, decoctions, diets, and 
oils/creams are used as oral medications and oils/creams are used as topical 
medications. pillas are the most common (nearly two thirds) preparation used, 
followed by powder, cream, decoction, diet, and oil. Pittu (ப6H) is a common diet 
which is prepared, usually with rice flour (sometimes with other grain flours such as 
Vigna mungo (L.) Hepper (Fabaceae), Eleusine coracana (L.) Gaertn. (Poaceae)), 
whereas preparations 4, 5, 6, and 7 (see Appendix B) are different types of pittu 
(ப6H) which are not commonly prepared. Preparations 44 (Santhanaathiyennai  - 
சதனாதிெய1ெணF), 46 (Piramehachchanthanaathiyennai - 
ப6ரேமக.சதனாதிெய1ெணF), and 47 (Neerilivuchchanthanaathiyennai - 
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ந7@ழி.சதனாதிெய1ெணF) (see appendix B) are the only three topical 
preparations.  
Plants, animal (including marine organism), and inorganic substances (minerals and 
metals) are used in the antidiabetic SL SM preparations. Almost all antidiabetic SL SM 
contain botanical drugs except preparation 41 (Piramehakkulihai - 
ப6ரேமக/ள+ைக) which contain only animal materials and preparation 42 
(Piramehakkulihai - ப6ரேமக/ள+ைக) which contain animal and inorganic 
ingredients. More than two thirds of preparations contain only plant ingredients, the 
vast majority (97 %) contain botanical drugs. Combination of plant and inorganic 
materials, combination of plant, inorganic, and animal materials, and combination of 
plant and animal materials are far less common. Furthermore, the majority of the 
ingredients in the preparations containing combination of different types of 
ingredients are also botanical drugs. Preparations 16 (Salakkalichchalpalavukkum 
kaimarunthu - சலகழி.சபல/ ைகம$!) and 53 (I8 – Thool) 
contain only a single ingredient i.e. one botanical drug. This is highlighting the 
importance of the plants in antidiabetic SL SM preparations. Combinations of all 
three types of ingredients are only used in 13 preparations. Preparation 46 
(Piramehachchanthanaathiyennai - ப6ரேமக.சதனாதிெய1ெணF), is the 
preparation which contains the most number (64) of ingredients including 54 plant 
species in 40 families. Almost all decoctions mentioned in Anonymous (2003) and 
Anonymous (2000) only contain plant materials with preparation 50 of Anonymous 
(2000) containing a combination of inorganic substance with plant material. Same 
plant part (bark) of different plant species are used in preparation 49 (Kudineer - 
/-ந7&) whereas different parts of Senna auriculata are the only ingredients in 
preparation 24 (Salakkalichchalpalavukkum kaimarunthu - 
சலகழி.சபல/ ைகம$!). Remarkably, almost all preparations 
containing only botanical drugs contain either toxic plant species or are from 
families known to yield many toxic species. Plant parts such as leaves, seeds, barks, 
stems, roots, fruits, flowers, rhizomes, and wood were used in antidiabetic SL SM 
preparations with seed being most commonly used. 
 
4.4.2. Plants used against diabetes – the wider economical – botanical context 
Many of the species are economically important, often cultivated / managed species 
and they are part of the wider Sri Lankan culture. Very often these species also have 
other uses such as a food, in ritual, in cosmetics and hygiene, as artefact, and as 
medicines used for other conditions. 
A large number of well-known and widely used food plants including Allium sativum, 
Curcuma longa, Tamarindus indica , various Piper species like P. cubeba., P. nigrum, 
Saccharum officinarum, and Zingiber officinale are also part of DM preparations, as 
are diverse fruits (Anacardium occidentale, Cocos nucifera, Phoenix dactylifera, Ph. 
pusilla., Punica granatum, Artocarpus heterophyllus, Musa × paradisiaca, and 
Syzygium cumini). Various green leaves are consumed as a part of a daily diet in SL, 
the most commonly used are Alternanthera sessilis, Ipomoea aquatica, Rivea ornata, 
Coccinia grandis, Mukia maderaspatana, and Murraya koenigii. Spices can be defined 
as being any of various pungent, aromatic plant substances used to flavour foods or 
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beverages. Cinnamomum verum, Myristica fragrans, Elettaria cardamomum, and 
Syzygium aromaticum are the common spices used in and exported from SL. Grains 
are consumed as the main part of the diet and Oryza sativa, Sesamum indicum, 
Vigna mungo, Cajanus cajan, Eleusine coracana, Panicum sumatrense, Paspalum 
scrobiculatum are the most commonly used.  
As SM is based on Saiva philosophy (ைசவ சிதாத - Saiva Siththantham) 
several plants used in Saiva rituals such as Elaeocarpus tuberculatus, Myroxylon 
balsamum, Cinnamomum cappara-coronde, Aegle marmelos, Azadirachta indica, 
Santalum album, and Curcuma aromatica are part of ingredients in the preparations. 
Crocus sativus, Chrysopogon zizanioides, Santalum album, and Curcuma aromatica 
the natural cosmetic substances used in Tamil tradition for centuries. In Saiva and 
Tamil traditions Ficus benghalensis aerial root and Azadirachta indica tender stem 
have been used to brush teeth also for centuries.  
Furniture is mostly made by heartwood which is strong and long lasting, such as 
Acacia chundra and Azadirachta indica are commonly used in SL. Moreover, plant 
used to obtain cotton wool and manufacturing cloth (Gossypium arboretum) and 
handicrafts (Bambusa bambos, Cocos nucifera, and Borassus flabellifer), aquatic 
plants (Nelumbo nucifera and Nymphaea pubescens), coastal plant (Pandanus 
odorifer), incense plants (Myroxylon balsamum and Santalum album) are also 
included in the preparations. Some plants such as Musa × paradisiaca, Cocos 
nucifera, and B. flabellifer are used for several purposes in daily life whereas each 
part of these plants has several uses.  
Many are locally used common medicinal plants with a wide distribution throughout 
south Asia and other continents such as Justicia adhatoda, Acorus calamus, 
Terminalia chebula, Ricinus communis, Vitex negundo, Azadirachta indica, Coscinium 
fenestratum, and Aloe vera. Weeds, i.e. species which are successful in disturbed 
environments, fast growing, and, often but not always herbaceous (Zimdahl, 1992) 
are, as in other medical traditions, employed frequently. Some of the weeds used 
include Cyperus rotundus, Euphorbia hirta, Boerhavia diffusa, Phyllanthus amarus or 
Tribulus terrestris.  Apart from the medicinal benefits, some weeds are also used as 
foods. For example, Achyranthes aspera and Cardiospermum halicacabum.   
 
4.5. Animal parts used 
More than one third of preparations contain animal parts as ingredients. Male deer 
musk (produced in a glandular sac in the lower abdomen), deer horn, civet musk 
(secreted in anal scent glands), rhinoceros horn, cow gallstone and urine, human 
colostrum (foremilk), ant egg, Coccus lacca (Shellac – resin excreted by the females 
of the lac insect) are used,  cow gallstones are  the most frequently used. Deer horn 
is used in calx form. Civet musk and rhinoceros horn are rare and they will be 
unavailable in the future. Also it is illegal to possess trade or use them. In addition, 
marine organisms such as pearl and red coral are also used in some preparations.  
 
4.6. Inorganic substances used 
Nearly half of the preparations contain inorganic ingredients. Metals such as 
mercury, arsenic, iron, silver, gold, zinc,  and lead as well as minerals such as rock 
salt, borax, cinnabar, biotite (black mica), saltpetre (potassium nitrate), Roche alum, 
graphite, beryl, asbestos, gypsum, stibnite (contains antimony sulphide), mica 
16 
 
(aluminium silicate), and magnetite, and sulfur are used in antidiabetic SL SM 
preparations. Magnetite is the most frequently used substance. Many of these 
substances are often highly poisonous (mercury, arsenic, etc.). Silver and gold are 
used in calx form whereas borax, cinnabar, and graphite are used in purified form. 
There are some studies which evaluated the toxicity of some inorganic substances 
used in Traditional Medicines. Biotite, for example, is used in several antidiabetic SL 
SM preparations. Biotite ash with different drug vehicles did not show any systemic 
toxicity (Srinivasa et al., 2010) and no genotoxicity in in vivo micronucleus assay and 
comet assay in Wistar rat of both sexes (Vardhini et al., 2010). ‘Detoxification 
procedures’ are employed in the preparation procedures while using some of these 
substances. For example mica (Wijenayake et al., 2014). Clearly such practices are of 
major concern and toxicological risks need to be addressed.  
 
4.7. Amount of ingredients and dosages used 
The amount of ingredients and dosages were converted from Tamil units where 
applicable and are presented in metric units (Appendix B). Standard Tamil weight 
measures, such as palam (பல, 1 பல = 40 g), panaavidai / kaasidai 
(பணாவ6ைட / காசிைட, 1 பணாவ6ைட = 488 g), and kalanju (கழ9,, 1 
கழ9, = 5 g) are used, whereas marakkaal (மரகா, 1 மரகா = 1200 ml), 
naali (நாழி, 1 நாழி = 600 ml), kalam (கல, 1 கல = 57.6 l) and koththu 
(ெகா!, 1 ெகா! = 150 ml) are used to measure volume of liquids. Moreover, 
nonstandard Tamil units such as 1 handful (1 ப6- – 1 pidi) – including half handful 
(½ ப6- – ½ pidi) and one quarter handful (¼ ப6- – ¼ pidi), size of a small coconut 
(சி ேதகாயள – siru thengaaiyalavu), as required (ேதைவயானள – 
thevaiyaanavalavu), size of an Areca catechu L. (Arecaceae) seed (பாகள – 
paakkalavu = 5 g), and lemon size (எ?மி.சகாயள – 
elumichchangkaayalavu) are also used.  
Tamil units such as size of an Areca catechu seed (5 g) have been standardised to 
equivalent in metric units. However, other Tamil units like one handful or half 
handful have not been standardised into metric units. Using non-standardised metric 
units would lead to inconsistency in the preparations because measured amount of 
ingredients would vary from one region to the next (lemon size, size of a small 
coconut etc.), and from person to person (handful, half handful, and one quarter 
handful). Therefore, it is recommended to standardise these units into metric units 
and encourage Siddha preparation manufacturers including local Siddha healers to 
use exact amounts during manufacturing and prescription.   
Most of the formally described preparations (see Appendix B) and preparations 
produced by local Siddha healers (passed on orally through the generations) are still 
used in SL today. However, local Siddha healers do not reveal any information about 
the preparations prescribed by them and it is only passed to the next generation as a 
secret.  
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5. Pharmacological information on individual species 
While in the previous parts at the composition and use of SL SM preparations were 
assessed, this part aims to assess the individual species in terms of the 
ethnopharmacological properties that made them suitable for use as antidiabetic 
remedies. Focus was exclusively on individual species used in SM since:  
 
1. The evaluation does not cover the complex preparations as such since no or 
insufficient information on these preparations is available and since at this 
stage it is not scientifically feasible to evaluate such multicomponent mixtures.  
 
2. None of the 60 antidiabetic SL SM preparations (Appendix B) have been 
studied scientifically.  Therefore, the pharmacological studies relevant for anti-
diabetic activity of individual species used in those 60 preparations were 
reviewed.  
Systematically reviewed information on the pharmacology studies such as parts 
used, pre-treatment of plant parts, extraction method, (active) compounds / fractions 
/ extracts, model, dosage / concentration, duration, way of administration, maximum 
nontoxic dosage and duration, and reference are presented in Appendix C. 
Pharmacological information relevant for understanding secondary complications of 
DM is not included.  
 
5.1. Pretreatment of plant part and extraction  
SM uses a range of methods for drying the botanical drugs including the use as fresh 
material (incl. pressed juices), shade or sun dried. However, in the pharmacological 
experiments mostly shade dried biomasses were employed. In some cases fresh 
materials were used. Solvents such as methanol, water, ethanol, mixture of different 
percentage aqueous ethanol were used in extraction procedures however, ethanol is 
most frequently used. In SM water and plant part juices are usually used as solvents. 
Thus future research should pay closer attention to such SL SM preparation practices 
especially the use of fresh plant material. Only when fresh material is unavailable 
solvent extraction of dried material should be employed whereas fresh plant material 
available freeze dried plant part juices should be employed as extracts for screening 
and further studies. Moreover, investigating the plant part used in Traditional 
Medicine would provide more positive results in pharmacology studies rather than 
trying a different one. 
 
5.2. Levels of evidence 
About 28 % (48 out of 171) of the overall species recorded (Appendix A) are globally 
distributed and used. These are very well studied such as Allium sativum, Zingiber 
officinale which were excluded from the further analysis and the scientific literature 
of the total 123 species were reviewed. The species studied for anti-diabetic activity 
(Appendix C) can be categorised into four levels based on the models used and 
other evidence available: 
 Species which have not been studied at all for antidiabetic related activities or 
did not show anti-diabetic activity ,  
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 Limited in vitro evidence and active compound identified,  
 In vivo evidence and active compound identified, and  
 Clinical evidence and active compound identified available.  
 
5.2.1. Species which have not been studied at all for antidiabetic related 
activities or did not show antidiabetic activity 
Nearly 41 % (51 out of 123) species reviewed have either not been studied at all or 
did not show anti-diabetic activity including Lannea coromandelica, Piper cubeba, 
Trachyspermum roxburghianum, Phoenix pusilla, and Saccharum officinarum. Species 
such as Limonia acidissima, Nymphaea pubescens, Hyoscyamus reticulatus, 
Aconitum heterophyllum, Cinnamomum cappara-coronde, Cissampelos pareira, 
Mesua ferrea, and Acacia chundra are used individually in five or more  preparations 
thus it is recommended to study the anti-diabetic activity of these species in either in 
vitro or in vivo models.  
 
5.2.2. Limited in vitro evidence and active compound identified 
According to the studies listed in Appendix C, α- and β-glucosidase, as well as α-
amylase inhibition, glycogen synthesis assays, and 3T3-L1 cell line were employed to 
investigate anti-diabetic activity in in vitro studies. The α-glucosidase inhibition assay 
was most frequently used. As mentioned above, approximately 90 % of people have 
DM globally have T2DM (WHO, 1999). Therefore, bioassays which are closely related 
to T2DM mentioned in section 3.2.1. In vitro models should be employed in future 
studies.  
Only 6 % (7 out of 123) of species reviewed such as Anacyclus pyrethrum, Bambusa 
bambos, and Gossypium arboretum had been studied only in in vitro bioassays and 
AAwas observed.  Abrus precatorius is the most frequently studied within the species 
studied up to this level.  Higher and lower concentrations of extracts were employed 
in some of the species studied up to this level.  Ethanol extract (29.25 μg/ml) of A. 
pyrethrum dried root showed inhibitory effect in the α-amylase inhibition assay 
(Kumar V.K. and Lalitha, 2014).  Also an aqueous extract (10.10 mg/ml) of G. 
arboreum dried leaves exhibited potent inhibitory activity in α-amylase inhibition 
assay (Kazeem et al., 2013). 
Active compounds have been identified only from A. precatorius and Dichrostachys 
cinerea. Three compounds (Lupenone, 24- methylenecycloartenone, and Luteolin) 
were identified from A. precatorius dried leaf, 50 % methanol extract detected a 
potent inhibitory activity in α-amylase inhibition assay (Yonemoto et al., 2014). The 
active compounds of the rest of the species should be identified and both these 
species and their antidiabetic active compounds should be studied in further in vivo 
models. However, this is the lowest level study of pharmacology evidence and 
provides insufficient evidence. 
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5.2.3. In vivo evidence and active compound identified 
T1DM and T2DM animal models (see 3.2.12. In vivo models) were employed to study 
anti-diabetic activity (Appendix C) using animal models such as rat, mouse, and 
rabbit with rat being the most frequently used animal. The majority of the studies 
were done in T1DM models (esp. Streptozotocin - induced diabetes) rather than 
T2DM models. T2DM models are db/db, KKAy, and high fat fed animal models with 
the db/db animal model being the most frequently employed one.  
Nearly 48 % (59 out of 123) of species reviewed including Tamarindus indica, 
Thespesia populnea, Ficus religiosa, Phyllanthus amarus, and Alpinia galangal have 
been studied up to this level. Syzygium cumini is most frequently studied in in vivo 
models within the species studied up to this level. As mentioned before higher and 
lower dosages of extracts were employed in in vivo studies. In some studies using 
T1DM models lower dosage such as 5 mg/kg showedanti-diabetic activity .  For an 
example 70 % methanol extract (5 mg/kg) of Musa × paradisiaca shade dried sucker 
orally administrated to Alloxan induced diabetic rat for 21 d decreased elevated 
blood glucose level (Akinlolu et al., 2015). In T2DM models ethyl acetate fraction of 
ethanol extract (100 mg/kg) of Acorus calamus dried radix orally administrated for 3 
weeks to db/db mouse significantly reduced serum glucose (Wu H. et al., 2009). High 
dosage such as 4000 mg/kg was also employed in some studies. For an example 
aqueous extract (4000 mg/kg) of Alpinia galangal dried rhizome orally administrated 
to Alloxan induced diabetic rabbit for 6 h significantly lowered the blood glucose 
level (Akhtar M.S. et al., 2002). However, this study did not reveal any toxicity of this 
dosage and the extremely high dose casts serious doubts at the pharmacological 
relevance of such data.  
Antidiabetic active compounds have been identified in 12 species including Acorus 
calamus, Areca catechu, Cheilocostus speciosus, Myristica fragrans, and Plumbago 
zeylanica. The majority of active compounds (five) have been identified in Oroxylum 
indicum. In T1DM models, β-amyrin palmitate (50 μg/kg) from Hemidesmus indicus 
root orally administered to Alloxan induced diabetic rat for 15 d showed remarkable 
lowered blood glucose levels  (Nair et al., 2014). Whereas in T2DM models, 
macelingan (10 mg/kg) from Myristica fragrans seed kernel orally administrated to 
db/db mouse for 14 d also reduced serum glucose (Han et al., 2008). 
Toxicity of active extracts and compounds were investigated in many studies. For 
example both aqueous and methanol (4000 mg/kg) extracts of Achyranthes aspera 
shade dried whole plant were orally administered to Alloxan induced diabetic rabbit 
decreased blood glucose levels in 4 h. However, toxicity study of this extract up to 
8000 mg/kg for 7 d revealed as nontoxic (Akhtar M. and Iqbal, 1991). As the highest 
dosage is nontoxic and half of the nontoxic dosage showed antidiabetic effects in 
shorter time this plant possesses promising antidiabetic properties.  Mycaminose 
(2000 mg/kg) identified from Syzygium cumini air dried mature seed administered to 
Streptozotocin induced diabetic rat for 14 d was revealed as nontoxic (Kumar A. et 
al., 2008). As higher dosage of this active compound showed not to be toxic this 
compound possesses a strong anti-diabetic activity, but again the relevance of is 
very doubtful due to the administered dosage. Hence, the antidiabetic active 
compound of the rest of the species showing anti-diabetic activity in in vivo models 
should be identified and both the species and their active compounds should be 
further studied in clinical models. Additionally, T1DM animal models are more 
frequently employed compared toT2DM models. As majority of the people have 
T2DM, more T2DM related animal models mentioned in section 3.2.4. Type 2 
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diabetes animal models should be therefore employed in in vivo antidiabetic 
pharmacological studies in the future. 
 
5.2.4. Clinical evidence and active compound identified 
T1DM, T2DM, and healthy volunteers were employed to investigate the anti-diabetic 
activity at this level with T2DM studies being the most frequently employed ones 
(Appendix C). Again as the aim is to study the anti-diabetic activity diabetic subjects 
should be employed. Employing normal subjects would lead to results of limited 
relevance.  
Approximately 5 % (6 out of 123) of the species reviewed have clinical evidence 
including Cyanthillium cinereum, Salacia reticulata, and Ficus racemose. An aqueous 
extract (1200 mg/d) of Ficus racemosa bark orally administrated to T2DM patients 
(18 men and 12 women who has T2DM for less than a year) for 1 month as the only 
treatment showed a significant reduction in fasting blood glucose concentration 
(Ahmed et al., 2011). This is the lowest dosage of an extract studied that showed 
efficacy in the group of plants studied up to this level. Hot water extract (equivalent 
to 20 g/kg of starting material) of Artocarpus heterophyllus mature leaf was 
administered orally to 20 normal and diabetic volunteers in each group 1 h before 
glucose loading. Reduced blood glucose level was observed after 30 min of glucose 
administration (Fernando et al., 1991). DM is a chronic disorder thus a chronic clinical 
study would provide more accurate results. A preparation (6 g/d) containing C. 
cinereum root (as well as unspecified ingredients) was administrated for 6 months 
orally to T2DM sufferers (who had the disease for more than 6 months) significantly 
decreased blood glucose levels (Bin Sayeed et al., 2013). This is a very high dosage. 
However, it is not reported how much C. cinereum root was present in the 
preparation.  
Antidiabetic active compounds (β-sitosterol, stigmasterol, and lanosterol) were only 
identified in Ficus racemosa within the plant species studied up to this level. Thus, it 
is recommended to identify the active compounds of the other species and in a next 
step these compounds should be studied in in vitro, in vivo, as well as clinical levels.  
 
5.3. Toxic plants 
Toxicity investigations play a very important role in assessing the therapeutic 
benefits of drugs and medicines derived from them. From the bibliographic data 
such as Roth et al. (2012) and Harborne et al (1996) some species may well have 
acute or chronic toxicity as well as posing the risk of teratogenicity and 
carcinogenesis as well as of allergic reactions. Nearly 49 % (60 out of 123) of plant 
species and various parts used in antidiabetic SL SM preparations were catagorised 
as toxic including Abrus precatorius, Strychnos potatorum, Aconitum heterophyllum, 
Hyoscyamus reticulatus, and Cycas circinalis.   However, a toxicity assessment of the 
plants used in antidiabetic SL SM preparations is beyond the scope of this 
manuscript.  
 
6. Conclusion 
This is the first study systematically assessing the importance of preparations and 
plants used in antidiabetic SL SM preparations. It documents the importance of such 
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treatments and creates the basis for a more methodical study of these local 
resources. This review documents 60 preparations and 171 species (in 73 families) 
used to treat DM in SL SM. Botanical drugs are very important in antidiabetic SL SM 
preparations and the most frequently used species is Senna auriculata. Currently, 
non-standardised units for ingredient measurements in the preparations and 
dosages are used; these need to be converted into standardised units.  
None of the 60 preparations documented in this review have been studied 
scientifically at all in any previous models. However, considerable pharmacology 
information on extracts of individual species is available. Therefore, anti-diabetic 
activity and toxicity of all preparations presented in this work should be scientifically 
studied using in vitro, in vivo, and clinical models in order to better understand their 
safety, pharmacological effects and clinical efficacy. Simple, preparations containing 
inexpensive, nontoxic, and common plant materials (such as preparations 25, 26, 27, 
28, 29, 49, 50, and 51) ingredients used preparations are the most suitable 
candidates for further scientific investigations such as a full characterisation of their 
chemical composition. Plant extracts contain mixtures of active, partly active, and 
inactive compound. The bioactivity of a plant extract is not dependent on a single 
compound thus, due to this complexity, results from bioactivity assessments are 
often not reproducible (Heinrich, 2010). Therefore, a clear phytochemical 
characterisation, using for example metabolomics techniques linked with in vitro or 
in vivo screening for bioactivity and toxicity, can be used for a better characterisation 
of phytomedicines.  
Indigenous and local medical knowledge has advanced and also made a greater 
contribution to global healthcare. Improvement of this knowledge base required that 
it incorporates evidence-based approaches to its practice. SM preparations produced 
by Sri Lanka Ayurvedic Drug Corporation (under the Sri Lankan Ministry of 
Indigenous Medicine) are believed to be consistent. On the other hand, SM 
preparations produced by Siddha healers have no assessment to be proved that they 
are consistent. Therefore, Sri Lankan Ministry of Indigenous Medicine should 
introduce new stricter laws to register the preparations, preparation methods, and 
ingredients, storage conditions, and shelf life prepared by local Siddha healers in 
terms to follow the consistency of SM preparations. Additionally, Sri Lankan Ministry 
of Indigenous Medicine should also carry out regular inspections to confirm the 
reliability of the preparations prepared by Siddha healers. Keeping information on 
such preparations secret or only accessible in a limited way would ultimately lead to 
its disappearance in the near future. Also any healers who are not willing to reveal 
the essential information on such preparations they use should be barred from 
registering and practising. Improved regulations of SM will also the likelihood of 
exclusion and avoidance of toxic materials such as mercury and arsenic being used in 
preparations.  
Yet, as there is no SL SM pharmacopoeia available. Hence, it is recommended to 
develop and published such a legally binding document in the near future which 
would be used as an important teaching material in SM education, regulations ,and 
easier for the Siddha healers and Siddha academic doctors for identifying and 
treating disorders.  
SM has been used for hundreds of years and it has shown numerous benefits, such 
as affordability, and ease of access, etc. Apart of these advantages, it also has certain 
limitations and one of the main ones being certain ingredients such as rhinoceros 
horn and rare plant species are difficult to come by and in some cases illegal to 
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handle. Therefore rare plant species which considered as important in the 
preparations should be cultivated to prevent from disappearance in the near future.      
Most of the pharmacology studies have been carried out in T1DM models. However, 
as stated above approximately 90 % of diabetics suffer from T2DM. Therefore, it is 
necessary to carry out further investigations in T2DM models. Fresh juices of various 
parts of plants are used as solvent in several antidiabetic SL SM preparations, for 
example, preparation 1. Hence, freeze dried fresh juices of plant materials could be 
used to study the pharmacological investigations where available, easily obtainable, 
and appropriate.     Also, the pharmacological studies reviewed are often 
methodologically problematic for other reasons, including, for example, unrealistic 
high doses or poor general design. Therefore, in the future more rigorous 
experimental approach will be needed. Additionally, the pharmacology studies of 
preparations containing only organic substances (expect some minerals and metals), 
should be tested and where they give better outcomes then, those organic 
substances can be excluded from future preparations. Further studies also should be 
performed to identify potential drug – drug interactions and side effects caused.  
One of the objectives of this work is to make such information publicly available to 
prevent its disappearance in the future and to ascertain that the local and traditional 
knowledge is promoted internationally. Only if this information is in the public 
domain will it be possible to establish that this knowledge is based on SM. Lastly, this 
work builds the foundation for a more efficient study of antidiabetic SL SM 
preparations and the plants used.  
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